Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.01
-0.07 (-0.99%)
At close: Jun 18, 2025, 4:00 PM
7.02
+0.01 (0.15%)
After-hours: Jun 18, 2025, 7:57 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
The 19 analysts that cover Teladoc Health stock have a consensus rating of "Buy" and an average price target of $9.6, which forecasts a 36.95% increase in the stock price over the next year. The lowest target is $7 and the highest is $12.
Price Target: $9.6 (+36.95%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 13 | 11 | 11 | 12 | 12 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 18 | 18 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -0.14% | May 28, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +28.39% | May 27, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +14.12% | May 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +71.18% | May 1, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +42.65% | May 1, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Decreased by -0.10%
Revenue Next Year
2.60B
from 2.57B
Increased by 1.32%
EPS This Year
-1.14
from -5.87
EPS Next Year
-0.80
from -1.14
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7B | 2.7B | 2.8B | ||
| Avg | 2.6B | 2.6B | 2.7B | ||
| Low | 2.4B | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7% | 6.9% | 8.5% | ||
| Avg | -0.1% | 1.3% | 2.0% | ||
| Low | -4.7% | -5.6% | -7.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.77 | -0.07 | 0.17 | ||
| Avg | -1.14 | -0.80 | -0.77 | ||
| Low | -1.41 | -1.45 | -1.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.